{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:09:41Z","timestamp":1794319781144,"version":"4.9.0"},"reference-count":61,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T00:00:00Z","timestamp":1766016000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82104184"],"award-info":[{"award-number":["82104184"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81961128020"],"award-info":[{"award-number":["81961128020"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82004124"],"award-info":[{"award-number":["82004124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Biofilms Microbiomes"],"DOI":"10.1038\/s41522-025-00862-z","type":"journal-article","created":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T15:18:01Z","timestamp":1766071081000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Synergistic effects of ferulic acid and wogonin on cholestatic liver injury via gut microbiota modulation"],"prefix":"10.1038","volume":"11","author":[{"given":"Xin","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruizhi","family":"Tao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feihui","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lizhi","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunlong","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhonghong","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,18]]},"reference":[{"key":"862_CR1","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/hep.28965","volume":"65","author":"PLM Jansen","year":"2017","unstructured":"Jansen, P. L. M. et al. The ascending pathophysiology of cholestatic liver disease. Hepatology 65, 722\u2013738 (2017).","journal-title":"Hepatology"},{"key":"862_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cld.2007.11.010","volume":"12","author":"G Zollner","year":"2008","unstructured":"Zollner, G. & Trauner, M. Mechanisms of cholestasis. Clin. Liver Dis. 12, 1\u201326 (2008).","journal-title":"Clin. Liver Dis."},{"key":"862_CR3","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/nrgastro.2013.151","volume":"11","author":"FG Schaap","year":"2014","unstructured":"Schaap, F. G., Trauner, M. & Jansen, P. L. M. Bile acid receptors as targets for drug development. Nat. Rev. Gastroenterol. Hepatol. 11, 55\u201367 (2014).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"862_CR4","doi-asserted-by":"publisher","first-page":"2547","DOI":"10.1016\/S0140-6736(18)30300-3","volume":"391","author":"JK Dyson","year":"2018","unstructured":"Dyson, J. K., Beuers, U., Jones, D. E. J., Lohse, A. W. & Hudson, M. Primary sclerosing cholangitis. Lancet 391, 2547\u20132559 (2018).","journal-title":"Lancet"},{"key":"862_CR5","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1016\/S2468-1253(21)00306-X","volume":"6","author":"SM Sahoo","year":"2021","unstructured":"Sahoo, S. M. & Mahapatra, S. J. Intrahepatic cholestasis of pregnancy: are we expecting too much from ursodeoxycholic acid?. Lancet Gastroenterol. Hepatol. 6, 886 (2021).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"862_CR6","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/S0140-6736(19)31270-X","volume":"394","author":"LC Chappell","year":"2019","unstructured":"Chappell, L. C. et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial. Lancet Lond. Engl. 394, 849\u2013860 (2019).","journal-title":"Lancet Lond. Engl."},{"key":"862_CR7","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41575-018-0011-z","volume":"15","author":"A Tripathi","year":"2018","unstructured":"Tripathi, A. et al. The gut-liver axis and the intersection with the microbiome. Nat. Rev. Gastroenterol. Hepatol. 15, 397\u2013411 (2018).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"862_CR8","doi-asserted-by":"crossref","unstructured":"Hsu, C. L. & Schnabl, B. The gut\u2013liver axis and gut microbiota in health and liver disease. Nat. Rev. Microbiol. 21, 719\u2013733 (2023).","DOI":"10.1038\/s41579-023-00904-3"},{"key":"862_CR9","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1002\/hep.29676","volume":"67","author":"P Hartmann","year":"2018","unstructured":"Hartmann, P. et al. Modulation of the intestinal bile acid\u2013FXR\u2013FGF15 axis improves alcoholic liver disease in mice. Hepatol. Baltim. Md 67, 2150\u20132166 (2018).","journal-title":"Hepatol. Baltim. Md"},{"key":"862_CR10","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1038\/s41579-022-00805-x","volume":"21","author":"SL Collins","year":"2023","unstructured":"Collins, S. L., Stine, J. G., Bisanz, J. E., Okafor, C. D. & Patterson, A. D. Bile acids and the gut microbiota: metabolic interactions and impacts on disease. Nat. Rev. Microbiol. 21, 236\u2013247 (2023).","journal-title":"Nat. Rev. Microbiol."},{"key":"862_CR11","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1038\/s41575-021-00566-7","volume":"19","author":"CD Fuchs","year":"2022","unstructured":"Fuchs, C. D. & Trauner, M. Role of bile acids and their receptors in gastrointestinal and hepatic pathophysiology. Nat. Rev. Gastroenterol. Hepatol. 19, 432\u2013450 (2022).","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"862_CR12","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1038\/s41586-020-2396-4","volume":"582","author":"M Funabashi","year":"2020","unstructured":"Funabashi, M. et al. A metabolic pathway for bile acid dehydroxylation by the gut microbiome. Nature 582, 566\u2013570 (2020).","journal-title":"Nature"},{"key":"862_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41392-023-01668-1","volume":"9","author":"JS Fleishman","year":"2024","unstructured":"Fleishman, J. S. & Kumar, S. Bile acid metabolism and signaling in health and disease: molecular mechanisms and therapeutic targets. Signal Transduct. Target. Ther. 9, 1\u201351 (2024).","journal-title":"Signal Transduct. Target. Ther."},{"key":"862_CR14","doi-asserted-by":"publisher","first-page":"eaan5931","DOI":"10.1126\/science.aan5931","volume":"360","author":"C Ma","year":"2018","unstructured":"Ma, C. et al. Gut microbiome\u2013mediated bile acid metabolism regulates liver cancer via NKT cells. Science 360, eaan5931 (2018).","journal-title":"Science"},{"key":"862_CR15","doi-asserted-by":"publisher","first-page":"106643","DOI":"10.1016\/j.phrs.2022.106643","volume":"188","author":"P Cheng","year":"2023","unstructured":"Cheng, P. et al. Capsaicin shapes gut microbiota and pre-metastatic niche to facilitate cancer metastasis to liver. Pharmacol. Res. 188, 106643 (2023).","journal-title":"Pharmacol. Res."},{"key":"862_CR16","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-34671-1","volume":"13","author":"Y Lei","year":"2022","unstructured":"Lei, Y. et al. Disulfiram ameliorates nonalcoholic steatohepatitis by modulating the gut microbiota and bile acid metabolism. Nat. Commun. 13, 6862 (2022).","journal-title":"Nat. Commun."},{"key":"862_CR17","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.celrep.2018.12.028","volume":"26","author":"K Wang","year":"2019","unstructured":"Wang, K. et al. Parabacteroides distasonis alleviates obesity and metabolic dysfunctions via production of succinate and secondary bile acids. Cell Rep. 26, 222\u2013235.e5 (2019).","journal-title":"Cell Rep."},{"key":"862_CR18","doi-asserted-by":"publisher","first-page":"1164","DOI":"10.1016\/j.apsb.2022.10.016","volume":"13","author":"X Fan","year":"2023","unstructured":"Fan, X. et al. Herbal formula BaWeiBaiDuSan alleviates polymicrobial sepsis-induced liver injury via increasing the gut microbiota Lactobacillus johnsonii and regulating macrophage anti-inflammatory activity in mice. Acta Pharm. Sin. B 13, 1164\u20131179 (2023).","journal-title":"Acta Pharm. Sin. B"},{"key":"862_CR19","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1136\/gutjnl-2017-315458","volume":"68","author":"T-R Wu","year":"2019","unstructured":"Wu, T.-R. et al. Gut commensal Parabacteroides goldsteinii plays a predominant role in the anti-obesity effects of polysaccharides isolated from Hirsutella sinensis. Gut 68, 248\u2013262 (2019).","journal-title":"Gut"},{"key":"862_CR20","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1002\/hep.30975","volume":"71","author":"Y Liu","year":"2020","unstructured":"Liu, Y. et al. Probiotic Lactobacillus rhamnosus GG prevents liver fibrosis through inhibiting hepatic bile acid synthesis and enhancing bile acid excretion in mice. Hepatology 71, 2050\u20132066 (2020).","journal-title":"Hepatology"},{"key":"862_CR21","doi-asserted-by":"crossref","unstructured":"Wu, L. et al. Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion. Gut Microbes 16, 2390176 (2024).","DOI":"10.1080\/19490976.2024.2390176"},{"key":"862_CR22","doi-asserted-by":"publisher","first-page":"231","DOI":"10.21037\/atm.2020.01.31","volume":"8","author":"Q Yao","year":"2020","unstructured":"Yao, Q. et al. Yin Zhi Huang, a traditional Chinese herbal formula, ameliorates diet-induced obesity and hepatic steatosis by activating the AMPK\/SREBP-1 and the AMPK\/ACC\/CPT1A pathways. Ann. Transl. Med. 8, 231 (2020).","journal-title":"Ann. Transl. Med."},{"key":"862_CR23","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12906-018-2290-x","volume":"18","author":"R-H Wu","year":"2018","unstructured":"Wu, R.-H. et al. Yinzhihuang oral liquid combined with phototherapy for neonatal jaundice: a systematic review and meta-analysis of randomized clinical trials. BMC Complement. Altern. Med. 18, 228 (2018).","journal-title":"BMC Complement. Altern. Med."},{"key":"862_CR24","doi-asserted-by":"publisher","first-page":"116418","DOI":"10.1016\/j.jep.2023.116418","volume":"310","author":"Y Tan","year":"2023","unstructured":"Tan, Y. et al. Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease. J. Ethnopharmacol. 310, 116418 (2023).","journal-title":"J. Ethnopharmacol."},{"key":"862_CR25","doi-asserted-by":"publisher","first-page":"119921","DOI":"10.1016\/j.lfs.2021.119921","volume":"284","author":"D Li","year":"2021","unstructured":"Li, D. et al. Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives. Life Sci. 284, 119921 (2021).","journal-title":"Life Sci."},{"key":"862_CR26","doi-asserted-by":"publisher","first-page":"9779","DOI":"10.1007\/s11033-020-05972-9","volume":"47","author":"DL Huynh","year":"2020","unstructured":"Huynh, D. L., Ngau, T. H., Nguyen, N. H., Tran, G.-B. & Nguyen, C. T. Potential therapeutic and pharmacological effects of Wogonin: an updated review. Mol. Biol. Rep. 47, 9779\u20139789 (2020).","journal-title":"Mol. Biol. Rep."},{"key":"862_CR27","doi-asserted-by":"publisher","first-page":"1854","DOI":"10.1002\/ptr.7386","volume":"36","author":"K Banik","year":"2022","unstructured":"Banik, K. et al. Wogonin and its analogs for the prevention and treatment of cancer: a systematic review. Phytother. Res. 36, 1854\u20131883 (2022).","journal-title":"Phytother. Res."},{"key":"862_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-6-r60","volume":"12","author":"N Segata","year":"2011","unstructured":"Segata, N. et al. Metagenomic biomarker discovery and explanation. Genome Biol. 12, R60 (2011).","journal-title":"Genome Biol."},{"key":"862_CR29","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1136\/gutjnl-2019-320135","volume":"70","author":"D Sun","year":"2021","unstructured":"Sun, D. et al. Angiogenin maintains gut microbe homeostasis by balancing \u03b1-Proteobacteria and Lachnospiraceae. Gut 70, 666\u2013676 (2021).","journal-title":"Gut"},{"key":"862_CR30","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1016\/j.chom.2025.04.022","volume":"33","author":"M Zhang","year":"2025","unstructured":"Zhang, M. et al. Microbiota-derived urocanic acid triggered by tyrosine kinase inhibitors potentiates cancer immunotherapy efficacy. Cell Host Microbe 33, 915\u2013931.e9 (2025).","journal-title":"Cell Host Microbe"},{"key":"862_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s40168-021-01036-7","volume":"9","author":"E Guerin","year":"2021","unstructured":"Guerin, E. et al. Isolation and characterisation of \u03a6crAss002, a crAss-like phage from the human gut that infects Bacteroides xylanisolvens. Microbiome 9, 89 (2021).","journal-title":"Microbiome"},{"key":"862_CR32","doi-asserted-by":"publisher","first-page":"906","DOI":"10.3389\/fimmu.2020.00906","volume":"11","author":"BJ Parker","year":"2020","unstructured":"Parker, B. J., Wearsch, P. A., Veloo, A. C. M. & Rodriguez-Palacios, A. The genus Alistipes: gut bacteria with emerging implications to inflammation, cancer, and mental health. Front. Immunol. 11, 906 (2020).","journal-title":"Front. Immunol."},{"key":"862_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.ab.2015.04.033","volume":"484","author":"AC Lamb","year":"2015","unstructured":"Lamb, A. C., Federico-Perez, R. A. & Xue, Z. Product in indole detection by Ehrlich\u2019s reagent. Anal. Biochem. 484, 21\u201323 (2015).","journal-title":"Anal. Biochem."},{"key":"862_CR34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.jhep.2013.09.026","volume":"60","author":"A Kosters","year":"2014","unstructured":"Kosters, A., Felix, J. C., Desai, M. S. & Karpen, S. J. Impaired bile acid handling and aggravated liver injury in mice expressing a hepatocyte-specific RXR\u03b1 variant lacking the DNA-binding domain. J. Hepatol. 60, 362\u2013369 (2014).","journal-title":"J. Hepatol."},{"key":"862_CR35","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1055\/s-0030-1253225","volume":"30","author":"M Wagner","year":"2010","unstructured":"Wagner, M., Zollner, G. & Trauner, M. Nuclear receptor regulation of the adaptive response of bile acid transporters in cholestasis. Semin. Liver Dis. 30, 160\u2013177 (2010).","journal-title":"Semin. Liver Dis."},{"key":"862_CR36","doi-asserted-by":"publisher","first-page":"156495","DOI":"10.1016\/j.phymed.2025.156495","volume":"139","author":"X Luo","year":"2025","unstructured":"Luo, X. et al. Yinzhihuang formula modulates the microbe\u2012gut\u2012liver axis and bile acid excretion to attenuate cholestatic liver injury. Phytomedicine 139, 156495 (2025).","journal-title":"Phytomedicine"},{"key":"862_CR37","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jep.2015.12.031","volume":"179","author":"F Chen","year":"2016","unstructured":"Chen, F. et al. Could the gut microbiota reconcile the oral bioavailability conundrum of traditional herbs?. J. Ethnopharmacol. 179, 253\u2013264 (2016).","journal-title":"J. Ethnopharmacol."},{"key":"862_CR38","doi-asserted-by":"publisher","first-page":"e00072","DOI":"10.1128\/MMBR.00072-19","volume":"84","author":"F Zhang","year":"2020","unstructured":"Zhang, F. et al. Bioavailability based on the gut microbiota: a new perspective. Microbiol. Mol. Biol. Rev. MMBR 84, e00072\u201319 (2020).","journal-title":"Microbiol. Mol. Biol. Rev. MMBR"},{"key":"862_CR39","doi-asserted-by":"publisher","first-page":"3865121","DOI":"10.1155\/2019\/3865121","volume":"2019","author":"Y Qu","year":"2019","unstructured":"Qu, Y., Zhang, Z., Lu, Y., Zheng, D. & Wei, Y. Network pharmacology reveals the molecular mechanism of cuyuxunxi prescription in promoting wound healing in patients with anal fistula. Evid. Based Complement. Altern. Med. 2019, 3865121 (2019).","journal-title":"Evid. Based Complement. Altern. Med."},{"key":"862_CR40","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1136\/gutjnl-2020-322260","volume":"69","author":"P Paone","year":"2020","unstructured":"Paone, P. & Cani, P. D. Mucus barrier, mucins and gut microbiota: the expected slimy partners?. Gut 69, 2232\u20132243 (2020).","journal-title":"Gut"},{"key":"862_CR41","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1016\/S2468-1253(21)00431-3","volume":"7","author":"T Breugelmans","year":"2022","unstructured":"Breugelmans, T. et al. The role of mucins in gastrointestinal barrier function during health and disease. Lancet Gastroenterol. Hepatol. 7, 455\u2013471 (2022).","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"862_CR42","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.3390\/nu13031018","volume":"13","author":"A Blesl","year":"2021","unstructured":"Blesl, A. & Stadlbauer, V. The gut-liver axis in cholestatic liver diseases. Nutrients 13, 1018 (2021).","journal-title":"Nutrients"},{"key":"862_CR43","doi-asserted-by":"publisher","first-page":"8351","DOI":"10.3390\/ijms21218351","volume":"21","author":"J Plaza-D\u00edaz","year":"2020","unstructured":"Plaza-D\u00edaz, J. et al. The gut barrier, intestinal microbiota, and liver disease: molecular mechanisms and strategies to manage. Int. J. Mol. Sci. 21, 8351 (2020).","journal-title":"Int. J. Mol. Sci."},{"key":"862_CR44","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s40104-019-0402-1","volume":"11","author":"P Guo","year":"2020","unstructured":"Guo, P., Zhang, K., Ma, X. & He, P. Clostridium species as probiotics: potentials and challenges. J. Anim. Sci. Biotechnol. 11, 24 (2020).","journal-title":"J. Anim. Sci. Biotechnol."},{"key":"862_CR45","doi-asserted-by":"publisher","first-page":"289","DOI":"10.4161\/gmic.19897","volume":"3","author":"HJ Flint","year":"2012","unstructured":"Flint, H. J., Scott, K. P., Duncan, S. H., Louis, P. & Forano, E. Microbial degradation of complex carbohydrates in the gut. Gut Microbes 3, 289\u2013306 (2012).","journal-title":"Gut Microbes"},{"key":"862_CR46","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1038\/s41579-018-0036-x","volume":"16","author":"EC Martens","year":"2018","unstructured":"Martens, E. C., Neumann, M. & Desai, M. S. Interactions of commensal and pathogenic microorganisms with the intestinal mucosal barrier. Nat. Rev. Microbiol. 16, 457\u2013470 (2018).","journal-title":"Nat. Rev. Microbiol."},{"key":"862_CR47","doi-asserted-by":"publisher","first-page":"1087","DOI":"10.1016\/j.chom.2023.05.026","volume":"31","author":"AS Luis","year":"2023","unstructured":"Luis, A. S. & Hansson, G. C. Intestinal mucus and their glycans: a habitat for thriving microbiota. Cell Host Microbe 31, 1087\u20131100 (2023).","journal-title":"Cell Host Microbe"},{"key":"862_CR48","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1016\/j.cell.2016.10.043","volume":"167","author":"MS Desai","year":"2016","unstructured":"Desai, M. S. et al. A dietary fiber-deprived gut microbiota degrades the colonic mucus barrier and enhances pathogen susceptibility. Cell 167, 1339\u20131353.e21 (2016).","journal-title":"Cell"},{"key":"862_CR49","doi-asserted-by":"publisher","first-page":"e01282","DOI":"10.1128\/mBio.01282-15","volume":"6","author":"NA Pudlo","year":"2015","unstructured":"Pudlo, N. A. et al. Symbiotic human gut bacteria with variable metabolic priorities for host mucosal glycans. mBio 6, e01282\u201315 (2015).","journal-title":"mBio"},{"key":"862_CR50","doi-asserted-by":"publisher","first-page":"111618","DOI":"10.1016\/j.mce.2022.111618","volume":"548","author":"JYL Chiang","year":"2022","unstructured":"Chiang, J. Y. L. & Ferrell, J. M. Discovery of farnesoid X receptor and its role in bile acid metabolism. Mol. Cell. Endocrinol. 548, 111618 (2022).","journal-title":"Mol. Cell. Endocrinol."},{"key":"862_CR51","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.cmet.2013.01.003","volume":"17","author":"SI Sayin","year":"2013","unstructured":"Sayin, S. I. et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab. 17, 225\u2013235 (2013).","journal-title":"Cell Metab."},{"key":"862_CR52","doi-asserted-by":"publisher","first-page":"2307981","DOI":"10.1002\/advs.202307981","volume":"11","author":"M Yang","year":"2024","unstructured":"Yang, M. et al. Antibiotic-induced gut microbiota dysbiosis modulates host transcriptome and m6A epitranscriptome via bile acid metabolism. Adv. Sci. 11, 2307981 (2024).","journal-title":"Adv. Sci."},{"key":"862_CR53","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-05336-9","volume":"9","author":"A Zarrinpar","year":"2018","unstructured":"Zarrinpar, A. et al. Antibiotic-induced microbiome depletion alters metabolic homeostasis by affecting gut signaling and colonic metabolism. Nat. Commun. 9, 2872 (2018).","journal-title":"Nat. Commun."},{"key":"862_CR54","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","volume":"24","author":"A Wahlstr\u00f6m","year":"2016","unstructured":"Wahlstr\u00f6m, A., Sayin, S. I., Marschall, H.-U. & B\u00e4ckhed, F. Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism. Cell Metab. 24, 41\u201350 (2016).","journal-title":"Cell Metab."},{"key":"862_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","volume":"3","author":"H Wang","year":"1999","unstructured":"Wang, H., Chen, J., Hollister, K., Sowers, L. C. & Forman, B. M. Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR. Mol. Cell 3, 543\u2013553 (1999).","journal-title":"Mol. Cell"},{"key":"862_CR56","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/joim.12140","volume":"275","author":"X Hu","year":"2014","unstructured":"Hu, X., Bonde, Y., Eggertsen, G. & Rudling, M. Muricholic bile acids are potent regulators of bile acid synthesis via a positive feedback mechanism. J. Intern. Med. 275, 27\u201338 (2014).","journal-title":"J. Intern. Med."},{"key":"862_CR57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s42003-024-06321-3","volume":"7","author":"D Zheng","year":"2024","unstructured":"Zheng, D. et al. Comparative profiling of serum, urine, and feces bile acids in humans, rats, and mice. Commun. Biol. 7, 1\u201313 (2024).","journal-title":"Commun. Biol."},{"key":"862_CR58","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1042\/CS20231465","volume":"138","author":"J Gillard","year":"2024","unstructured":"Gillard, J. & Leclercq, I. A. Importance of the gut microbiota in mice with a \u2018humanized\u2019 bile acid pool. Clin. Sci. Lond. Engl. 138, 61\u201364 (2024).","journal-title":"Clin. Sci. Lond. Engl."},{"key":"862_CR59","doi-asserted-by":"publisher","first-page":"119626","DOI":"10.1016\/j.carbpol.2022.119626","volume":"291","author":"W Zhou","year":"2022","unstructured":"Zhou, W. et al. The polysaccharides from the fruits of Lycium barbarum L. confer anti-diabetic effect by regulating gut microbiota and intestinal barrier. Carbohydr. Polym. 291, 119626 (2022).","journal-title":"Carbohydr. Polym."},{"key":"862_CR60","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/s41538-022-00156-0","volume":"6","author":"Y Zhang","year":"2022","unstructured":"Zhang, Y. et al. Stigmasterol attenuates hepatic steatosis in rats by strengthening the intestinal barrier and improving bile acid metabolism. Npj Sci. Food 6, 38 (2022).","journal-title":"Npj Sci. Food"},{"key":"862_CR61","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/S0016-5085(99)70461-0","volume":"117","author":"H Miyoshi","year":"1999","unstructured":"Miyoshi, H., Rust, C., Roberts, P. J., Burgart, L. J. & Gores, G. J. Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. Gastroenterology 117, 669\u2013677 (1999).","journal-title":"Gastroenterology"}],"container-title":["npj Biofilms and Microbiomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00862-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00862-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00862-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T16:03:35Z","timestamp":1766073815000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41522-025-00862-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,18]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["862"],"URL":"https:\/\/doi.org\/10.1038\/s41522-025-00862-z","relation":{},"ISSN":["2055-5008"],"issn-type":[{"value":"2055-5008","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,18]]},"assertion":[{"value":"25 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"231"}}